ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF19.27

F19.27

Billable

Other psychoactive substance dependence with psychoactive substance-induced persisting dementia

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F19.27 is a billable code used to indicate a diagnosis of other psychoactive substance dependence with psychoactive substance-induced persisting dementia.

Key Diagnostic Point:

F19.27 refers to a condition characterized by the dependence on psychoactive substances that are not classified under other specific categories, leading to a persistent form of dementia induced by the substance. This condition is marked by cognitive impairments, memory deficits, and changes in behavior that persist even after the cessation of substance use. The substances involved may include a variety of drugs such as hallucinogens, inhalants, or other non-specific psychoactive agents. The diagnosis requires a thorough assessment of the patient's history of substance use, the duration and severity of cognitive symptoms, and the exclusion of other potential causes of dementia. Treatment typically involves a multidisciplinary approach, including detoxification, cognitive rehabilitation, and psychotherapy, aimed at managing both the substance dependence and the cognitive deficits. Clinicians must be vigilant in monitoring the patient's progress and adjusting treatment plans accordingly.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Variety of psychoactive substances involved
  • Need for comprehensive patient history
  • Differentiation from other types of dementia
  • Potential for co-occurring mental health disorders

Audit Risk Factors

  • Inadequate documentation of substance use history
  • Failure to document cognitive assessments
  • Misclassification of the type of dementia
  • Lack of evidence for ongoing treatment plans

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use and cognitive assessments.

Common Clinical Scenarios

Patients presenting with memory loss and behavioral changes after substance use.

Billing Considerations

Ensure comprehensive documentation of both substance dependence and cognitive deficits.

Neurology

Documentation Requirements

Neurological evaluations and cognitive testing results.

Common Clinical Scenarios

Patients with persistent cognitive impairment following substance use.

Billing Considerations

Differentiating between substance-induced dementia and other neurodegenerative conditions.

Coding Guidelines

Inclusion Criteria

Use F19.27 When
  • According to ICD
  • 10 guidelines, F19
  • 27 should be used when there is clear evidence of substance dependence leading to persistent cognitive impairment
  • Documentation must support the diagnosis, including the duration of symptoms and the relationship to substance use

Exclusion Criteria

Do NOT use F19.27 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

96101CPT Code

Psychological testing

Clinical Scenario

Used for cognitive assessment in patients with suspected substance-induced dementia.

Documentation Requirements

Results of cognitive tests and interpretation.

Specialty Considerations

Psychiatrists and neurologists should collaborate on testing and interpretation.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, including the ability to capture the nuances of substance-induced cognitive impairments, which aids in better treatment planning and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, including the ability to capture the nuances of substance-induced cognitive impairments, which aids in better treatment planning and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, including the ability to capture the nuances of substance-induced cognitive impairments, which aids in better treatment planning and resource allocation.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F19.27 and other substance use disorder codes?

F19.27 specifically addresses cases where substance dependence leads to persistent cognitive impairment, distinguishing it from other codes that may not involve such cognitive effects.